✨ Shining a light on Neurofibromatosis ✨ There is no cure for Neurofibromatosis (NF), a rare genetic disorder that can cause cancer, epilepsy, disfigurement, blindness and learning difficulties including autism. With first-hand experience of this devastating illness, Con and Anne Petropoulos established The Flicker Of Hope Foundation to raise much needed funds to support researchers in their quest to find new treatments and improve the quality of life for those impacted by NF. Find out how Con and Anne's incredible dedication and generosity are helping to bring attention to this little-known condition and underpinning vital new research. Read the full story: https://lnkd.in/gnUzJgsF
WEHI (Walter and Eliza Hall Institute of Medical Research)
Research
Parkville, Victoria 26,792 followers
Brighter together
About us
WEHI (formerly the Walter and Eliza Hall Institute of Medical Research) brings the world’s brightest minds together to make life-changing discoveries. With more than 1000 researchers from across the globe, we are making discoveries for cancer, infectious and immune diseases, developmental disorders and healthy ageing. Our researchers are committed to long-term discovery, collaborating with partners in science, health, government, industry and philanthropy.
- Website
-
https://www.wehi.edu.au/
External link for WEHI (Walter and Eliza Hall Institute of Medical Research)
- Industry
- Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Parkville, Victoria
- Type
- Nonprofit
- Founded
- 1915
- Specialties
- Cancer, Inflammatory disorders, Immune disorders, Infectious diseases, medical research, and Healthy ageing
Locations
-
Primary
1G Royal Parade
Parkville, Victoria 3052, AU
-
4 Research Avenue
Bundoora, Victoria 3086, AU
Employees at WEHI (Walter and Eliza Hall Institute of Medical Research)
Updates
-
There are no drugs to slow or stop the progression of Parkinson’s disease, which affects movement as well as non-motor symptoms such as mood, sleep, memory and speech difficulties. A promising research collaboration between WEHI’s Lazarou Lab and the Martens lab at the University of Vienna has found two new proteins that regulate mitophagy – the process by which the energy-producing parts of our cells are broken down and recycled. Associate Professor Michael Lazarou said the discovery expands our understanding of how mitophagy is regulated and adds a fresh area of focus in their search for new therapies for neurodegenerative conditions such as Parkinson’s. The research, published in Nature Structural and Molecular Biology was supported by Aligning Science Across Parkinson’s (ASAP) and the Rebecca Cooper Medical Research Foundation. Read more on our website: https://lnkd.in/gW4GDfuf Read the study: https://lnkd.in/gcCpUYAX #ParkinsonsDisease #ParkinsonsResearch #PD #Parkinsons 📷 : Mitochondria (blue) being targeted by mitophagy (green and red)
-
-
We love meeting enthusiastic young scientists! Recently we welcomed this year’s cohort of ANZAAS students to WEHI for an up-close experience of medical research. Organised by the Australian & New Zealand Association for the Advancement of Science (ANZAAS), one of Australia’s oldest scientific associations, sixty high achieving science students in years 10, 11 and 12 attended a five-day residential program which also included visits to RMIT University and the Department of Defence Research. During their visit to WEHI the students toured our labs, heard about WEHI’s history of discoveries from Professor David Vaux, and enjoyed a presentation from Dr Rhiannon Morris, PhD, a postdoc researcher in the Blood Cells and Blood Cancer division. 📸 One: Professor David Vaux leading a tour of WEHI's Discovery Timeline 📸 Two: Dr Rhiannon Morris #WEHIResearch #STEM
-
-
WEHI’s National Drug Discovery Centre (NDDC) has announced that a Monash University-led research project into endometriosis is the latest beneficiary of subsidised access to the centre. The project will use the centre’s advanced robotic high-throughput screening technologies to speed up the drug discovery process for finding new treatments for endometriosis. The NDDC offers Australian medical researchers access to a fully staffed facility with drug screening expertise and the latest in robotic high-throughput technologies. The next round of applications for subsidised screens with the NDDC is now open until 31 October. Prospective applicants are encouraged to contact the NDDC for more information. Read more: https://lnkd.in/ghkrMzqF Monash Health Beverley Vollenhoven AM Paul Stupple
-
-
Why is there no insulin pill? This National Diabetes Week find out about a WEHI-led study that opens new avenues for the development of drugs that could replace daily insulin injections for people with type 1 diabetes. Read more: https://lnkd.in/gF7FHJ6K
-
We were thrilled to celebrate NAIDOC Week with DeadlyScience at an event that honours this year’s theme of ‘Keep the Fire Burning - Black, Loud and Proud’. On display was the new DeadlyScience wrapped tram designed by artist Jake Simon (Worimi-Biripi). The founder of DeadlyScience A/Prof Corey Tutt OAM announced WEHI’s Professor Misty Jenkins PhD AO as the newest DeadlyScience ambassador. WEHI is proud to be partnered with DeadlyScience in delivering the DeadlyScience Pathways Program which will pave the way for the next generation of Aboriginal and Torres Strait Islander scientists through an immersive biomedical science experience for secondary school students.
-
-
We’re celebrating transforming the cancer story as two eras of medical discovery converge to reveal a potential game-changing new approach to treating acute myeloid leukaemia (AML). A landmark research discovery at WEHI in the late 1980s led to the development of an anti-cancer drug called venetoclax. Today, our latest research is combining venetoclax with an emerging class of immunotherapy drugs called STING agonists, showing promising results in pre-clinical blood cancer models. This promising duo doesn’t just hold hope for patients with AML – it indicates for the first time that STING agonists could be successful in ways that had not been previously anticipated for blood cancers. Learn more about WEHI’s excellence in lifechanging medical research: https://lnkd.in/gVdVchbE #TransformingCancer #Science #Cancer #Leukaemia #CancerDrugs 📸 Photos: 1. The role of BCL-2 cell survival was explored in the early years by a research team including (L-R): Prof Jerry Adams, Prof Suzanne Cory AC, Prof Andreas Strasser and Prof David Vaux. 2. The team behind the new treatment for AML (L-R): Dr Sarah Diepstraten, Dr Eddie La Marca, Associate Professor Gemma Kelly, Dr Yin Yuan.
-
-
Aboriginal and Torres Strait Islander peoples have used art to share knowledge and stories for tens of thousands of years. First Nations art serves as a profound catalyst for reflection, learning and celebration of Aboriginal and Torres Strait Islander peoples and culture. At WEHI we’re proud to care for an amazing collection of artworks by First Nations artists. As part of our NAIDOC Week celebrations staff and students were invited to tour the pieces in our archives and on our walls, and learn about the people and stories behind their creation. Pictured: Professor Misty Jenkins PhD AO leading staff and students on one of this week's tours #NAIDOC #NAIDOCWeek #NAIDOC2024 #KeepTheFireBurning
-
-
Congratulations to WEHI researchers awarded these exceptional grants! Lead investigator Professor Wai-Hong Tham, for the project "Rapid and adaptable nanobody platform for generation of therapeutics against pathogens of pandemic potential”, with co-investigators Professor Colin Pouton, Associate Professor Melissa Call and Dr Phillip Pymm. Lead investigator Professor David Komander, for the project “Antivirals targeting papain-like protease (PLpro)”, with co-investigators Dr Shane Devine, Dale Calleja, Professor Guillaume Lessene and Associate Professor Kym Lowes. Pioneering projects that have potential to transform how future pandemics are managed, with thanks to the generous support of the Cumming Global Centre for Pandemic Therapeutics.
We are thrilled to announce the 10 recipients of a collective $5 million in the second and final round of the Cumming Global Centre’s inaugural Foundation Grants Program. Developing a first of its kind therapeutic agent to conveniently treat respiratory viruses and screening 200 animal viruses to assess human pandemic risk and inform proactive treatment development are just two of the pioneering projects that received funding. With Round Two open to applicants worldwide for the first time, the Centre will fund its first two international lead investigators from the University of York and the University of Oxford. We will also fund a further eight lead investigators from CSIRO, WEHI (Walter and Eliza Hall Institute of Medical Research), Monash University, UNSW Griffith University and The University of Queensland. This follows $17 million that was awarded to researchers from The Peter Doherty Institute for Infection and Immunity, University of Melbourne and The Royal Melbourne Hospital in Round One earlier this year, bringing our total investment in innovative research to $22 million across 32 projects to date. Visit our website for more details: https://lnkd.in/gU5SPxVD
-
Myrna Dewar spent over two decades as a nurse, caring for cancer patients. She never expected that, one day, she’d be one of them. In the winter edition of Illuminate, Myrna describes how she came to be a steadfast supporter of medical research, and why she chose to leave a gift to WEHI in her Will.
The power of research: Myrna's legacy
https://www.wehi.edu.au